Vitro S.A.B. de C.V (VITROA) fair value: what the stock is really worth
As of Sep 24, 2026: fair value of Vitro S.A.B. de C.V MXN 3.45, price MXN 4.55, upside -24.1%, quality 70 out of 100. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.
Watch Vitro S.A.B. de C.V for free, get notified when fair value or trend changes. Plus fair value for all 35,000+ stocks, 14 days of Pro free, no card.Watch for freePro now: $1 first month
69 individual criteria per stock, every one traceableSee the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Sep 24, 2026.
How to read this chart
60‑month range 3.45 MXN – 29.59 MXN · fair‑value band 2.68 MXN – 6.79 MXN · the 4.55 MXN price screens above the 3.45 MXN fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Sep 24, 2026.
Follow Vitro S.A.B. de C.V in your weekly email
Every Wednesday you see whether Vitro S.A.B. de C.V is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Vitro, S.A.B. de C.V., through its subsidiaries, produces, processes, distributes, and markets inorganic chemical products worldwide. The company provides sodium carbonate and bicarbonate, calcium chloride, and sodium chloride. It serves automotive, glass, detergent, water treatment, pharmaceutical, food, oil, road deicing, and livestock sectors.
Show more
Vitro, S.A.B. de C.V., through its subsidiaries, produces, processes, distributes, and markets inorganic chemical products worldwide. The company provides sodium carbonate and bicarbonate, calcium chloride, and sodium chloride. It serves automotive, glass, detergent, water treatment, pharmaceutical, food, oil, road deicing, and livestock sectors. Vitro, S.A.B. de C.V. was founded in 1909 and is based in San Pedro Garza García, Mexico.
Stock analysis
Vitro S.A.B. de C.V (VITROA) currently trades at 4.55 MXN, while our model-based Fair Value estimate is 3.45 MXN, implying the stock looks roughly 31.7% overvalued today.
Show more
Valuation
Bull case: the Growth DCF group reads highest at a median of 5.16 MXN per share, and 4 of the 23 models we run sit above the 4.55 MXN price.
Bear case: the Dividend Discount group reads lowest at 0.4800 MXN, and 19 of the 23 models stay below the price. Evidence for this calculation is low.
Scenario range: 2.68 MXN (bear) to 6.79 MXN (bull), the price of 4.55 MXN sits inside it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 70/100 (solid quality), in the Basic Materials sector.
Weak Growth: Revenue is shrinking: the last year, the last three and the last five years are all negative.
Vitro S.A.B. de C.V reported revenue of $311M in FY2023 versus $2.2B in FY2019, a compound −38.6%/yr. Reported net income was $129M in FY2023, compounding +19.1%/yr from FY2019.
Key figures
Market cap 2.4B MXN (≈ $136M) · P/S ratio 8.43 · EPS (TTM) −3.62 MXN · Net margin 41.6% · Return on equity 17.3% · Return on assets (EBIT) 2.8% · Operating margin 3.0% · Revenue (TTM) $284M.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 48 out of 100 (low confidence).
What moves the price
The share trades about 26% below its 52-week high and 32% above its 52-week low, currently below its 200-day average.
For context, the median of 10 Basic Materials peers we cover trades at −47% fair-value upside, at −24%, VITROA screens cheaper than that median.
Fair Value models
Bear 2.68 MXNFair Value 3.45 MXNBull 6.79 MXN
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target.Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.40/100
Revenue is shrinking: the last year, the last three and the last five years are all negative.
Revenue growth 1 year
−86.8%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−44.0%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−32.6%
Revenue growth 23 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−17.8%
’12
’13
’14
’15
’16
’17
’18
’19
’20
’21
’22
’23
What shareholders gained per year (last 5 years) ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate.
−4.0%
Earnings growth per share plus dividend.
Earnings per share, growth per year−4.0%
Dividend (yield on the price)0.0%
Profit margin 2018 to 2023 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.11% → 12%
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Building Materials · 258 stocks
Beats the industry median on 7/13 measures
A mixed picture versus its industry peers.
Valuation
Quality Score70 · Top 25%
Fair Value upside−21% · Below median
Profitability
Return on equity (TTM)17% · Top 25%
Return on assets−1% · Bottom 25%
Net margin (TTM)61% · Top 25%
Operating margin (TTM)3% · Below median
Growth and dividend
Revenue growth16% · Top 25%
Dividend yield (TTM)0.0% · Bottom 25%
Balance sheet
Debt / equity0.17× · Above median
Valuation Multiplesvs Building Materials median · lower = cheaper
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Cite: Fair Value Calculator (2026). "Vitro S.A.B. de C.V Fair Value". https://www.fairvalue-calculator.com/stock/VITROA
Frequently asked questions
Is Vitro S.A.B. de C.V (VITROA) overvalued or undervalued?
As of Sep 24, 2026, our model estimates a fair value of 3.45 MXN versus a price of 4.55 MXN, about −24% upside (overvalued).
What is the fair value of VITROA?
Our model-based fair value for Vitro S.A.B. de C.V is 3.45 MXN (as of Sep 24, 2026), built from audited fundamentals. The current price: 4.55 MXN.
What is the quality score of VITROA?
Vitro S.A.B. de C.V has a Quality Score of 70/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Vitro S.A.B. de C.V (VITROA)?
Our model-based price target is the fair value of 3.45 MXN (as of Sep 24, 2026) from 23 valuation models. Cautious scenario 2.68 MXN, optimistic scenario 6.79 MXN. It is a calculation from audited fundamentals, not an analyst target.
What is the Vitro S.A.B. de C.V stock forecast for 2026?
Our models put fair value at 3.45 MXN, about −24% upside versus a price of 4.55 MXN (overvalued). Cautious scenario 2.68 MXN, optimistic scenario 6.79 MXN. The calculation is refreshed regularly with new filings.
What is the revenue of Vitro S.A.B. de C.V (VITROA)?
Vitro S.A.B. de C.V reported trailing-twelve-month revenue of about $284M (latest available figure, as of Sep 24, 2026).
What is the intrinsic value of Vitro S.A.B. de C.V (VITROA)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Vitro S.A.B. de C.V it is 3.45 MXN per share (as of Sep 24, 2026), against a price of 4.55 MXN. It is the blended result of 23 valuation models (cash flow, earnings, asset, dividend).
Is Vitro S.A.B. de C.V stock overvalued or undervalued in 2026?
As of Sep 24, 2026, VITROA trades above its calculated fair value: price 4.55 MXN, fair value 3.45 MXN, a gap of about −24% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of VITROA?
No. The price is what the market pays today (4.55 MXN); the fair value is what the company's own numbers justify (3.45 MXN). For Vitro S.A.B. de C.V the two are 1.10 MXN per share apart. That gap is exactly why we show both numbers side by side.
How much is Vitro S.A.B. de C.V worth?
The market values Vitro S.A.B. de C.V at about 2.4B MXN (market capitalisation, as of Sep 24, 2026). Per share that is 4.55 MXN; our models calculate a fair value of 3.45 MXN per share.
What do the bullish and bearish scenarios say about VITROA?
Our models span a range for Vitro S.A.B. de C.V: cautious scenario 2.68 MXN, base 3.45 MXN, optimistic 6.79 MXN per share (as of Sep 24, 2026, price 4.55 MXN). The range comes from different growth and margin assumptions, not from analyst opinions.
How solid is the balance sheet of Vitro S.A.B. de C.V (VITROA)?
Balance-sheet figures for Vitro S.A.B. de C.V (as of Sep 24, 2026): return on equity 17.3%, debt of 0.17 per unit of equity. They feed the Quality Score of 70/100, which measures business quality independently of the share price.
How far is VITROA from its 52-week high?
Vitro S.A.B. de C.V trades at 4.55 MXN, about 26% below its 52-week high of 6.12 MXN and 32% above the low of 3.45 MXN (as of Sep 24, 2026). Distance from the high says nothing about value: that is what the fair value of 3.45 MXN is for.
Which stocks are comparable to Vitro S.A.B. de C.V?
From the same area (Basic Materials) we also value CRH plc, Holcim AG, Vulcan Materials Company, UltraTech Cement Limited, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Vitro S.A.B. de C.V stock attractive at the current price?
The data as of Sep 24, 2026: price 4.55 MXN, calculated fair value 3.45 MXN (−24%), Quality Score 70/100, from 23 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of VITROA calculated?
We run Vitro S.A.B. de C.V through 23 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of 3.45 MXN, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 14.0 % above its aggregate fair value. Vitro S.A.B. de C.V itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Vitro S.A.B. de C.V (VITROA)?
The closing price on Sep 24, 2026 was 4.55 MXN. Our model-based fair value is 3.45 MXN, about −24% upside (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Vitro S.A.B. de C.V right now?
A high-quality business (quality 70/100), yet the market already pays well above fair value. Quality at a full price, with little margin of safety. A fairly wide model range (2.68 MXN to 6.79 MXN) leaves room in how you read the outcome. Evidence is limited here (fewer models, shorter history), so the fair value is a rougher estimate than usual.
Key figures of Vitro S.A.B. de C.V
How large is the market capitalisation of Vitro S.A.B. de C.V (VITROA)?
The market capitalisation of Vitro S.A.B. de C.V is 2.4B MXN (≈ $136M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Vitro S.A.B. de C.V (VITROA)?
The price-to-sales ratio of Vitro S.A.B. de C.V is 8.43 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Vitro S.A.B. de C.V (VITROA)?
Earnings per share at Vitro S.A.B. de C.V are −3.62 MXN. Earnings per share over the last twelve months: total profit spread across every single share.
What is the net margin of Vitro S.A.B. de C.V (VITROA)?
The net margin of Vitro S.A.B. de C.V is 41.6% (fiscal year 2023). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Vitro S.A.B. de C.V (VITROA)?
The return on equity (ROE) of Vitro S.A.B. de C.V is 17.3% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Vitro S.A.B. de C.V (VITROA)?
On an EBIT basis the return on assets of Vitro S.A.B. de C.V is 2.8% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Vitro S.A.B. de C.V (VITROA)?
The operating margin of Vitro S.A.B. de C.V is 3.0% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Vitro S.A.B. de C.V (VITROA)?
Revenue at Vitro S.A.B. de C.V is growing +15.5% versus a year earlier (3y avg −44.0%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Vitro S.A.B. de C.V (VITROA)?
Earnings per share at Vitro S.A.B. de C.V are growing +291% versus a year earlier. How much earnings per share grew versus a year earlier.
How much free cash flow does Vitro S.A.B. de C.V (VITROA) generate?
The free cash flow of Vitro S.A.B. de C.V is $255M (fiscal year 2023). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
How much net debt does Vitro S.A.B. de C.V (VITROA) carry?
The net debt of Vitro S.A.B. de C.V is $74.8M (fiscal year 2023, ≈ 0.3 yrs of FCF). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed
Watch Vitro S.A.B. de C.V in the live analysis
One click puts Vitro S.A.B. de C.V on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.
